Altimmune, Inc. (ALT) - Cash per Share

Corporate emblem and logo of Altimmune, Inc. (ALT)

Altimmune, Inc. (ALT) development relies on a research and development cycle that is largely independent of macroeconomic factors. The daily price action of liquid assets per share on the GURU.Markets chart demonstrates a pivot driven by the preparation of peptide synthesis capacities and the success of pemvidutide in combating obesity. Meanwhile, the value of 1.35 shows the current cash reserve, confirming the company's financial stability.

ALT - altimmune.com Cash per Single Share over the range 07/04/2022 - 11/20/2026

Analytical breakdowns for Altimmune, Inc.

- stock value and consensus price forecast:
- cash position and cash flow details:
Comprehensive company analysis:ALT Altimmune, Inc.
Manufactured product of Altimmune

This indicator reflects the volume of liquid assets per common share, allowing for an assessment of the issuer's internal capital cushion and level of financial autonomy. An analysis of the cash per share trend confirms the ability of Altimmune, Inc. (ALT) to maintain operational resilience and fund raw material procurement from external peptide manufacturers, thereby minimizing dependence on third-party contractors.